Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Series B Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance at Dec. 31, 2020		$ 54	$ 24,074,348	$ (19,413,458)	$ (15,351)	$ 4,645,593
Balance (in Shares) at Dec. 31, 2020		537,558
Issuance of common stock, common stock warrants and prefunded warrants (net of offering costs of $1,591,600)		$ 27	13,407,605			13,407,632
Issuance of common stock, common stock warrants and prefunded warrants (net of offering costs of $1,591,600) (in Shares)		273,079
Issuance of common stock and warrants (net of offering costs of $572,500)		$ 10	4,427,491			4,427,501
Issuance of common stock and warrants (net of offering costs of $572,500) (in Shares)		99,010
Warrant exercise		$ 5	359,508			359,513
Warrant exercise (in Shares)		45,069
Stock-based compensation			1,322,821			1,322,821
Stock-based compensation (in Shares)		4,293
Cumulative translation adjustment					32,937	32,937
Net loss				(14,313,705)		(14,313,705)
Balance at Dec. 31, 2021		$ 96	43,591,773	(33,727,163)	17,586	9,882,292
Balance (in Shares) at Dec. 31, 2021		959,009
Stock-based compensation			620,798			620,798
Stock-based compensation (in Shares)		1,801
Issuance of common stock (net of offering costs of $1,014,896)		$ 33	5,985,070			5,985,103
Issuance of common stock (net of offering costs of $1,014,896) (in Shares)		329,412
Issuance of Series B preferred stock	$ 1,000					1,000
Issuance of Series B preferred stock (in Shares)	2,000,000
Redemption of Series B preferred stock	$ (1,000)		990			(10)
Redemption of Series B preferred stock (in Shares)	(2,000,000)
Fractional shares adjusted for reverse split		$ 1	(1)
Fractional shares adjusted for reverse split (in Shares)		11,891
Cumulative translation adjustment					4,420	4,420
Net loss				(11,371,953)		(11,371,953)
Balance at Dec. 31, 2022		$ 130	$ 50,198,630	$ (45,099,116)	$ 22,006	$ 5,121,650
Balance (in Shares) at Dec. 31, 2022		1,302,113